24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Uveitis
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:15
OpenWeb seeks insolvency protection as former Israeli unicorn faces cash-flow crisis
20:45
Paragon co-founder Idan Nurik to leave and launch AI infrastructure startup
19:35
Prime Minister’s Office and Finance Ministry oppose $4.2 billion Zim sale
18:32
Melisron CEO Ophir Sarid dies at 54 after sudden illness
More stories
Buzz
Most popular
Daily
Weekly
1
Oracle’s co-CEOs got $350 million in equity awards. A year later, the stock had lost half its value
2
Intel has 70 people working on quantum computing. Its CEO is betting on the next frontier
3
Assaf Rappaport: “I received an envelope with $30 billion written on it. I said no right away”
4
Intel CEO says he uses AI agents every day to cut hours of research to minutes
5
U.S. bank Valley National buys Israeli fintech Bluevine for $340 million
More news
Uveitis
1 stories about Uveitis
How one female CEO overcame adversity to find a cure for Uveitis
04.02.22
|
Roni Dori
"I see us building a large company that will focus on the eye, beyond Uveitis. Our technology has tremendous potential to treat other diseases that cause blindness, and treat millions of patients," says Dr. Daphne Haim-Langford, who suffers from Uveitis and founded Tarsier Pharma